Institutional Investors Are Buying Hyperliquid Strategies. Should You?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Finance & Markets
Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700
Key PointsThe transaction involved the disposal of 7,500 shares.
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
Key PointsPerrigo is a healthcare company with a huge 8.3% dividend yield.
Up 20% in 1 Day, is Hyperliquid Worth Buying Hand Over Fist Right Now?
The decentralized crypto exchange appears to have an ally in the White House.
Apple Announced Its Largest-Ever Stock Buyback Under Tim Cook's Leadership. Here's Why the Size of the Repurchase Program Matters for Shareholders.
No company has bought back more of its shares than Apple over the last decade.